Filed before 2025Filed 23 May 2023
Ensoma, Inc. has sold $129M so far
Ensoma, Inc., a biotech company based in Boston, MA, has sold $129M so far in its equity round, according to a filing dated 23 May 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 23 May 2023
- First filed
- 9 January 2023
- Round
- Equity round (amended filing)
- Amount sold
- $129M
- Offering size
- $129M
- Investors so far
- 22
- Based in
- Boston, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 98% of the 1,396 tracked raises with an amount filed in 2023, and than 95% of the 142 in biotech.
Ensoma, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 23 May 2023 | Amended filing | $129M | This raise |
| 9 Jan 2023 | New filing | $79M | This raise |
More with 5AM Ventures on the board
- S2N Health Inc.$3M
- Ride Health, Inc.$15.5M
- Huma.AI, Inc.$1.02M
- Itiliti Health, Inc.$574K
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.